Published in Clinical Oncology Week, November 21st, 2005
Scientists from the United States conducted a study "to provide a single-institution analysis of the impact of age and race on biochemical control after radiotherapy (RT) administered in different prostate cancer scenarios. Age and race are among the most controversial prognostic factors in determining outcome after RT."
"Proper understanding of these prognostic factors can assist in both treatment decision-making and the general understanding of the natural history of prostate cancer. The records of 527 consecutive nonmetastatic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.